Recruiting NA Cognitive Impairment

New treatment option for Cognitive Impairment

Official title LSVT Big and Dual Task Training in Cognitive Impaired Patients

ClinicalTrials.gov ID: NCT06927362

What this study is testing

What it's testing
The goal of this study ifs to determine the comparative effects of Lee Silverman voice treatment Big and dual task training on balance, cognition and functional mobility in older adults with cognitive impairment. Perform LSVT big four times in a week for about 4 months.
  • Time commitment: about 4 months

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • Both male and female patients.
  • Age limit for patients will be above 65.
  • Patients with Mild and moderate cognitive impairment patients MoCA 13-25.
  • Patients with Berge balance scale value 41-50.
  • Patients who give consent to participate in study and undergo relevant test.

You likely can't join if

  • Patients with any musculoskeletal disorder in which these exercises are contraindicated.
  • Patients using any walking aids.
  • Patients with hearing impairment.
  • Patients with other neurological conditions with limit the patient participation in planned exercise like stroke, Parkinson's.
  • Patients with diagnosed psychiatric disorder or taking medication that affect cognitive function within 24 hours.

The study team makes the final eligibility decision.

Where it's taking place

  • Lahore, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 4 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.